Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: Implications for clinical use

Mini-Reviews in Medicinal Chemistry

Volumn 4, Issue 1, 2004, Pages 41-48

  Sakurai, Hiromu ^a   Fugono, Jun ^a   Yasui, Hiroyuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bioavailability; Blood circulation monitoring electron paramagnetic resonance (BCM EPR); Diabetes mellitus; Enteric coated capsule; Insulinomimetic activity; Pharmacokinetic analysis; Vanadyl compound

Indexed keywords

BIS(6 METHYLPICOLINATO)OXOVANADIUM; BIS(PICOLINATO)OXOVANADIUM; CISPLATIN; INSULIN; UNCLASSIFIED DRUG; VANADATE SODIUM; VANADYL DERIVATIVE; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; CONTROLLED STUDY; DIABETES MELLITUS; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG SYNTHESIS; DRUG USE; NONHUMAN; RAT; REVIEW; STEADY STATE; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; ANIMALS; CAPSULES; DIABETES MELLITUS, EXPERIMENTAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; GELATIN; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; PICOLINIC ACIDS; RATS; RATS, WISTAR; VANADATES; VANADIUM COMPOUNDS;

EID: 3042568737     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557043487574     Document Type: Review

References (29)

1. National Diabetes Data Group, Diabetes 1979, 28, 1039.
2. Kuzuya, T.; Matsuda, A. Diabetes Care 1997, 20, 219.
3. Heyliger, C. E.; Tahiliani, A. G.; McNeill, J. H. Science 1985, 227, 1474.
4. Meyerovitch, J.; Farfel, Z.; Sack, J.; Shechter, Y. J. Biol. Chem. 1987, 262, 6658.
5. Pederson, R. A.; Ramanadham, S.; Buchan, A. M. J.; McNeill, J. H. Diabetes 1989, 38, 1390.
6. Sakurai, H.; Tsuchiya, K.; Nukatsuka, M.; Sofue, M.; Kawada, J. J. Endocrinol. 1990, 126, 451.
7. Thompson, K. H.; McNeill, J. H.; Orvig, C. Chem. Rev. 1999, 99, 2561.
8. Sakurai, H. The Chem. Rec. 2002, 2, 237.
9. Sakurai, H.; Kojima, Y.; Yoshikawa, Y.; Kawabe, K.; Yasui, H. Coord. Chem. Rev. 2002, 226, 187.
10. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385.
11. Cohen, N.; Halberstam, M.; Shlimovich, P.; Chang, C. J.; Shamoon, H.; Rossetti, L. J. Clin. Invest. 1995, 95, 2501.
12. Halberstam, M.; Cohen, N.; Shlimovich, P.; Rossetti, L.; Shamoon, H. Diabetes 1996, 45, 659.
13. Boden, G.; Chen, X.; Ruiz, J.; Van Rossum, G. D. V.; Turco, S. Metabolism 1996, 45, 1130.
14. Goldfine, A. B.; Patti, M. E.; Zuberi, L.; Goldstein, B. J.; LeBlanc, R.; Landaker, E. J.; Jiang, Z. Y.; Willsky, G. R.; Kahn, C. R. Metabolism 2000, 49, 400.
15. Cusi, K.; Cukier, S.; DeFronzo, R. A.; Torres, M.; Puchulu, F. M.; Redondo, J. C. P. J. Clin. Endocrinol. Metab. 2001, 86, 1410.
16. Takeehi, K.; Tamura, H.; Yamaoka, K.; Sakurai, H. Free Rad. Res. 1997, 26, 483.
17. Yasui, H.; Takechi, K.; Sakurai, H. J. Inorg. Biochem. 2000, 78, 185.
18. Sakurai, H.; Sano, H.; Takino, T.; Yasui, H. J. Inorg. Biochem. 2000, 80, 99.
19. Takino, T.; Yasui H.; Yoshitake, A.; Hamajima, Y.; Matsushita, R.; Takada, J.; Sakurai, H. J. Biol. Inorg. Biochem. 2001, 6, 133.
20. Yasui, H.; Tamura, A.; Takino, T.; Sakurai, H. J. Inorg. Biochem. 2002, 91, 327.
21. Cantley, L. C.; Resh, M. D. Jr.; Guidotti, G. Nature 1978, 272, 552.
22. Sakurai, H.; Nishida, M.; Kida, K.; Koyama, M.; Takada, J. Inorg. Chim. Acta. 1987, 138, 149.
23. Fujimoto, S.; Fujii, K.; Yasui, H.; Matsushita, R.; Takada, J.; Sakurai, H. J. Clin. Biochem. Nutr. 1997, 23, 113.
24. Fugono, J.; Yasui, H.; Sakurai, H. J. Pharm. Pharmacol. 2001, 53, 1247.
25. Setyawati, I. A.; Thompson, K. H.; Yuen, V. G.; Sun Y.; Battell, M.; Lyster, D. M.; Vo, C.; Ruth, T. J.; Zeisler, S.; McNeill, J. H.; Orvig, C. J. Appl. Physiol. 1998, 84, 569.
26. Kararli, T. T. Biopharm. Drug Disposit. 1995, 16, 351.
27. Fugono, J.; Yasui, H.; Sakurai, H. J. Pharm. Pharmacol. 2002, 54, 611.
28. Tanigawara, Y.; Yamaoka, K.; Nakagawa, T.; Uno, T. J. Pharm. Sci. 1982, 71, 1129.
29. Lima, J. J.; Jusko, W. J. Clin. Pharmacol. Ther. 1980, 28, 262.